Perrigo Co. has begun shipping Loratadine-D 12-hour extended-release tablets for allergies.


Perrigo, Loratadine-D 12-hour extended-release tablets, Claritin-D 12-hour, store-brand equivalent, Schering-Plough, Joseph Papa, nasal allergy symptoms










































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Perrigo rolls out store-brand Claritin-D 12

February 14th, 2012

ALLEGAN, Mich. – Perrigo Co. has begun shipping Loratadine-D 12-hour extended-release tablets for allergies.

The company said Tuesday that its product is the store-brand equivalent to Schering-Plough's Claritin-D 12-hour extended release tablets.

"This launch is another milestone for our Consumer Healthcare segment, which is expected to launch many important, new store-brand products during this fiscal year," commented Perrigo chairman and chief executive officer Joseph Papa. "We are excited to bring this important store-brand medication to consumers for the first time and continue our focus on making quality health care more affordable."

Claritin-D 12 is indicated for the treatment of nasal allergy symptoms. Its estimated annual sales are about $111 million, according to Wolters Kluwer data cited by Perrigo.

Advertisement